Back to last page

---

Health News

333

Medications

FDA Expands Approval of J&J Prostate Cancer Drug

FDA Expands Approval of J&J Prostate Cancer Drug

apdigital_2012_12_10_ap.online.health-medical_DA3342100_news_ap_org.anpa

WASHINGTON (AP) -- The Food and Drug Administration on Monday expanded approval of Johnson & Johnson's prostate cancer pill Zytiga for men with an earlier stage of the disease.

1466209

InteliHealth

2012-12-10

t

Associated Press

2013-01-09

drug,prostate cancer,cancer

21291